GRZAN Medical Device Registration Services in El Salvador

1. Key takeaways

GRZAN provides end-to-end device compliance services for El Salvador across four stages. The first is access determination: the definition in Article 3.14, the exclusions in Articles 2.2 and 6.3.5, and the Clase A, B, C and D classification in Article 6.3.1 (a). The second is the three pre-market authorisations: premises authorisation under Article 6.2, sanitary registration under Article 6.3, and import authorisation under Article 6.4. The third is dossier preparation and submission, comprising the twelve general items in Article 6.3.2 together with the additional items for four product types, at six, seven, nine and nine items respectively. The fourth is post-market maintenance: renewal and the annual fee under Article 6.3.1 (f) and (g), inspections and sampling under Article 6.5, and technical vigilance under RTS 11.03.04:23. The fifty articles in this volume are arranged along that service chain. Read in sequence, they follow a device from the question of whether it is regulated at all, through the permissions needed to place it on the market, to the recurring obligations that keep those permissions alive.

• Access determination comes first because classification drives dossier depth, clinical evidence and fee tier.
• Premises authorisation, sanitary registration and import authorisation are three separate permissions, not one.
• The reliance route can reduce duplicate GMP auditing, but it remains a discretionary decision and does not waive local duties.
• Three annual payments sustain a registration, and missing any one of them starts the suspension route.
• Local delivery depends on licensed partners holding the premises authorisation and on three registered professional subjects.

2. Legal basis

The service chain maps onto specific provisions rather than to general practice. The table below shows where each stage of the work is anchored, together with the instruments that supply the reliance route and the fee basis.

3. Expert insights

The first point is that GRZAN operates its own holder network in Southeast Asia and works through local collaboration in El Salvador. We hold our own entities in six countries, Singapore, Malaysia, Thailand, Indonesia, Vietnam and the Philippines, and can act directly as local registration holder, importer and authorised representative in those markets. In El Salvador, delivery is through the GRZAN registration team working with locally licensed partners, including importers and distributors that hold a premises authorisation, together with a Director Técnico, a Profesional responsable and an Apoderado responsable registered with the SRS.

The second point is that classification is the first decision in a Salvadoran project and the step that saves the most money. Article 6.3.1 (a) takes intended use as its axis and applies four criteria: duration of contact, degree of invasiveness, manner of invasiveness, and whether the device releases a drug or energy. These produce four classes, Clase A to Clase D. The class assigned directly determines the depth of the dossier and the clinical assessment that must be prepared, so writing the intended use statement accurately before filing avoids a large volume of corrective work later.

The third point is the equivalence route for Chinese manufacturers, which this volume returns to repeatedly as a cost lever. The URDM section of the reliance policy, at section 6.8, recognises ISO 13485, MDSAP, and EU 2017/745 and 2017/746 certificates as equivalent evidence of good manufacturing practice. A Chinese device company already holding these certificates can avoid a duplicate audit. Two limits apply: reliance is a discretion exercisable by the SRS under section 6.7, and it does not waive local obligations.

The fourth point is that three recurring annual payments are the most frequently omitted items in a budget. They are the annual fee of USD 25.00 under Article 3.3, the annual maintenance fee for market vigilance of USD 85.00 under Article 3.4, and the annual premises renewal fee, which is USD 36.00 for an importer and USD 480.00 for a manufacturing laboratory. Missing any one of them triggers suspension and the initiation of cancellation, so GRZAN sets each of the three as a separate calendar reminder rather than folding them into a single payment run.

4. Practical recommendations

• Begin each project with access determination, settling definition, exclusion list and risk class in one pass.
• For multi-model products, calculate the registration tier first, from USD 150.00 for one to twenty-five codes, and assess whether a bundled submission is preferable.
• Where ISO 13485, MDSAP or EU certificates are already held, prepare the verification material for a reliance application at the same time.
• Set three separate reminders for the annual fee, the market vigilance maintenance fee and the premises renewal fee.
• Build the vigilance system on RTS 11.03.04:23 and appoint a vigilance liaison for each premises.
• Where a local holder, importer or the three professional subjects are required, confirm the collaboration arrangement with GRZAN’s locally licensed partners.

5. Verification checklist

• □ Access determination covering definition, exclusions and class is complete
• □ The registration tier and bundling strategy have been calculated
• □ Verification material for a reliance application is prepared
• □ The three annual payments have separate reminders
• □ The vigilance system and liaison are in place
• □ The local holder and professional subject arrangements are confirmed

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Salvadoran market. Our team manages Ministry of Health (MINSAL) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com